T0	Participants 55 104	in melanoma patients with high serum MMP-8 levels
T1	Participants 387 395	melanoma
T2	Participants 416 486	from 460 patients with stage IIB-IIIC melanoma were analyzed for MMP-8
T3	Participants 841 882	months in patients with high MMP-8 levels
T4	Participants 1019 1056	survival for patients with high MMP-8